Rational design of HIV vaccine and microbicides: report of the EUROPRISE annual conference
<p>Abstract</p> <p>EUROPRISE is a Network of Excellence sponsored from 2007 to 2011 by the European Commission within the 6th Framework Program. The Network encompasses a wide portfolio of activities ranging from an integrated research program in the field of HIV vaccines and micro...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-07-01
|
Series: | Journal of Translational Medicine |
Online Access: | http://www.translational-medicine.com/content/8/1/72 |
id |
doaj-034d6dd23ed245f09d11bfc076653ec3 |
---|---|
record_format |
Article |
spelling |
doaj-034d6dd23ed245f09d11bfc076653ec32020-11-24T22:19:33ZengBMCJournal of Translational Medicine1479-58762010-07-01817210.1186/1479-5876-8-72Rational design of HIV vaccine and microbicides: report of the EUROPRISE annual conferenceMainetti LaraKlein KatjaHornig JuliaHallengärd DavidGrupping KatrijnDispinseri StefaniaDieltjens TessaDe Haes WinniDa Costa KellyColeman AdamBorggren MarieBiswas PriscillaWahren BrittaPalma PaoloReudelsterz MarcSeifried JannaSelhorst PhilippeSköld Annettevan Gils Marit JWeber CarolineShattock RobinScarlatti Gabriella<p>Abstract</p> <p>EUROPRISE is a Network of Excellence sponsored from 2007 to 2011 by the European Commission within the 6th Framework Program. The Network encompasses a wide portfolio of activities ranging from an integrated research program in the field of HIV vaccines and microbicides to training, dissemination and advocacy. The research program covers the whole pipeline of vaccine and microbicide development from discovery to early clinical trials. The Network is composed of 58 partners representing more than 65 institutions from 13 European countries; it also includes three major pharmaceutical companies (GlaxoSmithKline, Novartis and Sanofi-Pasteur) involved in HIV microbicide and vaccine research. The Network displays a dedicated and informative web page: <url>http://www.europrise.org</url>. Finally, a distinguishing trait of EUROPRISE is its PhD School of students from across Europe, a unique example in the world of science aimed at spreading excellence through training.</p> <p>EUROPRISE held its second annual conference in Budapest in November, 2009. The conference had 143 participants and their presentations covered aspects of vaccine and microbicide research, development and discovery. Since training is a major task of the Network, the students of the EUROPRISE PhD program summarized certain presentations and their view of the conference in this paper.</p> http://www.translational-medicine.com/content/8/1/72 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Mainetti Lara Klein Katja Hornig Julia Hallengärd David Grupping Katrijn Dispinseri Stefania Dieltjens Tessa De Haes Winni Da Costa Kelly Coleman Adam Borggren Marie Biswas Priscilla Wahren Britta Palma Paolo Reudelsterz Marc Seifried Janna Selhorst Philippe Sköld Annette van Gils Marit J Weber Caroline Shattock Robin Scarlatti Gabriella |
spellingShingle |
Mainetti Lara Klein Katja Hornig Julia Hallengärd David Grupping Katrijn Dispinseri Stefania Dieltjens Tessa De Haes Winni Da Costa Kelly Coleman Adam Borggren Marie Biswas Priscilla Wahren Britta Palma Paolo Reudelsterz Marc Seifried Janna Selhorst Philippe Sköld Annette van Gils Marit J Weber Caroline Shattock Robin Scarlatti Gabriella Rational design of HIV vaccine and microbicides: report of the EUROPRISE annual conference Journal of Translational Medicine |
author_facet |
Mainetti Lara Klein Katja Hornig Julia Hallengärd David Grupping Katrijn Dispinseri Stefania Dieltjens Tessa De Haes Winni Da Costa Kelly Coleman Adam Borggren Marie Biswas Priscilla Wahren Britta Palma Paolo Reudelsterz Marc Seifried Janna Selhorst Philippe Sköld Annette van Gils Marit J Weber Caroline Shattock Robin Scarlatti Gabriella |
author_sort |
Mainetti Lara |
title |
Rational design of HIV vaccine and microbicides: report of the EUROPRISE annual conference |
title_short |
Rational design of HIV vaccine and microbicides: report of the EUROPRISE annual conference |
title_full |
Rational design of HIV vaccine and microbicides: report of the EUROPRISE annual conference |
title_fullStr |
Rational design of HIV vaccine and microbicides: report of the EUROPRISE annual conference |
title_full_unstemmed |
Rational design of HIV vaccine and microbicides: report of the EUROPRISE annual conference |
title_sort |
rational design of hiv vaccine and microbicides: report of the europrise annual conference |
publisher |
BMC |
series |
Journal of Translational Medicine |
issn |
1479-5876 |
publishDate |
2010-07-01 |
description |
<p>Abstract</p> <p>EUROPRISE is a Network of Excellence sponsored from 2007 to 2011 by the European Commission within the 6th Framework Program. The Network encompasses a wide portfolio of activities ranging from an integrated research program in the field of HIV vaccines and microbicides to training, dissemination and advocacy. The research program covers the whole pipeline of vaccine and microbicide development from discovery to early clinical trials. The Network is composed of 58 partners representing more than 65 institutions from 13 European countries; it also includes three major pharmaceutical companies (GlaxoSmithKline, Novartis and Sanofi-Pasteur) involved in HIV microbicide and vaccine research. The Network displays a dedicated and informative web page: <url>http://www.europrise.org</url>. Finally, a distinguishing trait of EUROPRISE is its PhD School of students from across Europe, a unique example in the world of science aimed at spreading excellence through training.</p> <p>EUROPRISE held its second annual conference in Budapest in November, 2009. The conference had 143 participants and their presentations covered aspects of vaccine and microbicide research, development and discovery. Since training is a major task of the Network, the students of the EUROPRISE PhD program summarized certain presentations and their view of the conference in this paper.</p> |
url |
http://www.translational-medicine.com/content/8/1/72 |
work_keys_str_mv |
AT mainettilara rationaldesignofhivvaccineandmicrobicidesreportoftheeuropriseannualconference AT kleinkatja rationaldesignofhivvaccineandmicrobicidesreportoftheeuropriseannualconference AT hornigjulia rationaldesignofhivvaccineandmicrobicidesreportoftheeuropriseannualconference AT hallengarddavid rationaldesignofhivvaccineandmicrobicidesreportoftheeuropriseannualconference AT gruppingkatrijn rationaldesignofhivvaccineandmicrobicidesreportoftheeuropriseannualconference AT dispinseristefania rationaldesignofhivvaccineandmicrobicidesreportoftheeuropriseannualconference AT dieltjenstessa rationaldesignofhivvaccineandmicrobicidesreportoftheeuropriseannualconference AT dehaeswinni rationaldesignofhivvaccineandmicrobicidesreportoftheeuropriseannualconference AT dacostakelly rationaldesignofhivvaccineandmicrobicidesreportoftheeuropriseannualconference AT colemanadam rationaldesignofhivvaccineandmicrobicidesreportoftheeuropriseannualconference AT borggrenmarie rationaldesignofhivvaccineandmicrobicidesreportoftheeuropriseannualconference AT biswaspriscilla rationaldesignofhivvaccineandmicrobicidesreportoftheeuropriseannualconference AT wahrenbritta rationaldesignofhivvaccineandmicrobicidesreportoftheeuropriseannualconference AT palmapaolo rationaldesignofhivvaccineandmicrobicidesreportoftheeuropriseannualconference AT reudelsterzmarc rationaldesignofhivvaccineandmicrobicidesreportoftheeuropriseannualconference AT seifriedjanna rationaldesignofhivvaccineandmicrobicidesreportoftheeuropriseannualconference AT selhorstphilippe rationaldesignofhivvaccineandmicrobicidesreportoftheeuropriseannualconference AT skoldannette rationaldesignofhivvaccineandmicrobicidesreportoftheeuropriseannualconference AT vangilsmaritj rationaldesignofhivvaccineandmicrobicidesreportoftheeuropriseannualconference AT webercaroline rationaldesignofhivvaccineandmicrobicidesreportoftheeuropriseannualconference AT shattockrobin rationaldesignofhivvaccineandmicrobicidesreportoftheeuropriseannualconference AT scarlattigabriella rationaldesignofhivvaccineandmicrobicidesreportoftheeuropriseannualconference |
_version_ |
1725778475695996928 |